New shot for bleeding disorders enters first human tests
Disease control
Recruiting now
This early-stage study tests a new drug called SR604 in healthy volunteers and people with hemophilia A, B, or factor VII deficiency. The goal is to check safety and how the drug works in the body. About 31 participants will receive the drug as a shot under the skin.
Phase: PHASE1 • Sponsor: Equilibra Bioscience LLC • Aim: Disease control
Last updated May 17, 2026 05:35 UTC